A Novel Treatment for Aphasia and Apraxia of Speech : Measurement of Outcomes
A Novel Treatment for Aphasia and Apraxia of Speech: Measurement of Outcomes
Sponsor: VA Office of Research and Development
Listed as NCT01979159, this NA trial focuses on Aphasia and Apraxia of Speech and remains completed. Sponsored by VA Office of Research and Development, it has been updated 10 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Jul 2019 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jun 2018 — Jul 2019 [monthly]
Active Not Recruiting NA
-
Oct 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
-
May 2017 — Oct 2017 [monthly]
Active Not Recruiting NA
Phase: PHASE1 → NA
-
Jan 2017 — May 2017 [monthly]
Active Not Recruiting PHASE1
First recorded
Oct 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- VA Office of Research and Development
For direct contact, visit the study record on ClinicalTrials.gov .